Qorvo Biotechnologies Sensor-Based Technology Provides Rapid Reference-Lab Quality Tests At Point-of-Care

This white paper describes Qorvo Biotechnologies’ Bulk Acoustic Wave (BAW) immunosensor detection platform designed for point-of-care applications and describes analytical and functional sensitivity testing on human Thyroid Stimulating Hormone (hTSH) as an example. The Qorvo Biotechnologies’ platform is targeted to be central lab matched, with the goal of providing clinicians data that will enable quicker decision making across multiple disease states, such as in cardiac and infectious disease segments, where time to result and high performance are critical factors in the patient care workflow.